T3 · Product exporter position

Ireland exports of Medicaments: containing alkaloids or their derivatives, containing norephedrine or its salts, for therapeutic or prophylactic uses, (not packaged for retail sale) (HS 300343)

See where Ireland stands in medicaments: containing alkaloids or their derivatives, containing norephedrine or its salts, for therapeutic or prophylactic uses, (not packaged for retail sale): export scale, destination breadth, market position, growth, and reported trade history.

Exporter IRLHS6 300343Latest year 2024Rapid growth

Latest exports

$1.9MLatest observed lane total

Destination markets

2Reported active markets

Three-year growth

+393.6%Annualized change

Destination HHI

4,569Destination concentration

Weighted share

97.8%Reported market position

Exporter evidence

How strong is Ireland in Medicaments: containing alkaloids or their derivatives, containing norephedrine or its salts, for therapeutic or prophylactic uses, (not packaged for retail sale)?

Reported exporter totals and calculated indicators for HS 300343. Values retain their observed coverage period.

Exporter scale

Latest exports$1.9M
Current 2024 exports$619.8K
Three-year average$318.0K
Historical peak$1.9M

Market position

Active destinations2
Destination HHI4,569
Weighted share97.8%
Share change+95.4 pp

Competitiveness

Three-year growth+393.6%
Volatility0
Maximum drawdown0.3%
TrendRapid growth
MeasureValueWhat it describes
ExporterIrelandCountry represented by this profile
Latest observed exports$1.9MSum of latest observed destination-lane values
Current 2024 exports$619.8KCommon-year comparison where reported
Three-year growth+393.6%Annualized change in exporter totals
Five-year growth-11.2%Annualized change in exporter totals
Leading destinationVNMDestination with the largest observed export value
Leading destination share59.1%Share of observed exporter totals
Destination concentration4,569HHI across destination markets
Weighted share change+95.4 ppValue-weighted latest change in market share
Limited-history lanes100%Share of lanes with shorter history

Destination markets

Where does Ireland sell medicaments: containing alkaloids or their derivatives, containing norephedrine or its salts, for therapeutic or prophylactic uses, (not packaged for retail sale)?

Leading destination observations ranked by reported export value, with market position and access context.

DestinationLatest exportsMarket shareGrowthAccessSignal
Viet Nam$1.1M100%+0%FTA reportedDeclining
USA, Puerto Rico and US Virgin Islands$619.8K100%+0%Not reportedDeclining
Democratic People\'s Republic of Korea$51.8K100%+0%Not reportedDeclining
Japan$28.7K56.6%+10.8%FTA reportedStable
Germany$26.4K11.3%+300.2%FTA reportedAccelerating
India$16.2K100%+1,075.1%Not reportedAccelerating

Destination

Viet Nam

Latest exports
$1.1M
Market share
100%
Growth
+0%
Access
FTA reported
Signal
Declining

Destination

USA, Puerto Rico and US Virgin Islands

Latest exports
$619.8K
Market share
100%
Growth
+0%
Access
Not reported
Signal
Declining

Destination

Democratic People\'s Republic of Korea

Latest exports
$51.8K
Market share
100%
Growth
+0%
Access
Not reported
Signal
Declining

Destination

Japan

Latest exports
$28.7K
Market share
56.6%
Growth
+10.8%
Access
FTA reported
Signal
Stable

Destination

Germany

Latest exports
$26.4K
Market share
11.3%
Growth
+300.2%
Access
FTA reported
Signal
Accelerating

Destination

India

Latest exports
$16.2K
Market share
100%
Growth
+1,075.1%
Access
Not reported
Signal
Accelerating

Price intelligence

How does Ireland's price position vary?

Price comparisons are shown where market-level unit-value observations are available. They describe reported trade values and quantities, not quoted selling prices.

Highest reported price

India: $339.5K / ton.

Lowest reported price

Former Arab Republic of Yemen: $8.6K / ton.

Median price

$339.5K / ton across reported markets.

Export trend

Reported export history

Annual observations for Ireland and HS 300343 where available.

YearExportsYear-on-year changeActive destinations
1995$66.2KNot reported23
2001$51.8K-21.8%1
2006$92.2K+78%22
2017$1.1M+1,118.7%2
2021$5.2K-99.5%1
2023$16.2K+215.1%1
2024$619.8K+3,716.2%2

Exporter context

Ireland economy and trade network

The exporter profile adds country-level trade and structural context to the selected product position. These indicators describe the country overall and are not limited to HS 300343.

Ireland has reported exports of $256.9B and a trade balance of $135.2B in 2024.

Available structural indicators include 83% trade openness, 28.2% investment, and 270 active trade partners.

Reported values

Export totals and destination values describe reported merchandise trade for the stated exporter, HS6 classification, and available year.

Calculated indicators

Growth, concentration, weighted share, volatility, drawdown, and price comparisons are calculated from reported observations.

Coverage

Missing values remain “Not reported”. Country-level indicators are presented separately from product-level observations.

Frequently asked questions

Questions about Ireland medicaments: containing alkaloids or their derivatives, containing norephedrine or its salts, for therapeutic or prophylactic uses, (not packaged for retail sale) exports

Quick answers based on the figures and coverage shown on this page.

How strong is this exporter?

Use latest exports, destination breadth, growth, concentration, and weighted share together rather than relying on one measure.

Which markets are most important?

The destination table ranks reported markets by the latest observed export value.

Does the price section show quotes?

No. It summarizes reported trade value and quantity observations converted to unit values.

What should be checked next?

Compare this exporter with buyer markets, corridors, and the product overview before making a commercial decision.